WHO ICTRP trial
Effect of Mineralocorticoid on Brown Fat in Humans with Primary Aldosteronism…
ACTRN12614001129673 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12614001129673 |
|---|---|
| Public title | Effect of Mineralocorticoid on Brown Fat in Humans with Primary Aldosteronism who will be treated with Surgery |
| Scientific title | Effect of Mineralocorticoid on Brown Fat in humans with primary aldosteronism who will be treated with surgery |
| Primary sponsor | Professor Ken Ho |
| Secondary sponsors | Dr Moe Thuzar |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Primary aldosteronism ;Obesity; Primary aldosteronism Obesity;Diet and Nutrition - Obesity;Metabolic and Endocrine - Other metabolic disorders |
| Interventions | Newly diagnosed primary aldosteronism who will be treated with surgical removal of the affected adrenal gland. Brown fat activity (using PET-CT scan) and energy expenditures (using indirect calorimetry) will be assessed before and at least… |
| Registration date | Oct 23, 2014 |
| Target size | 12 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: